BIOR
Vanguard Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-697,330
| Closed | -$350K | – | 4388 |
|
|
2024
Q3 | $350K | Hold |
697,330
| – | – | ﹤0.01% | 4049 |
|
|
2024
Q2 | $460K | Buy |
697,330
+121,300
| +21% | +$80.1K | ﹤0.01% | 4031 |
|
|
2024
Q1 | $634K | Buy |
576,030
+68,095
| +13% | +$74.9K | ﹤0.01% | 3956 |
|
|
2023
Q4 | $686K | Buy |
507,935
+229,183
| +82% | +$309K | ﹤0.01% | 3940 |
|
|
2023
Q3 | $605K | Buy |
278,752
+34,310
| +14% | +$74.5K | ﹤0.01% | 4000 |
|
|
2023
Q2 | $941K | Buy |
244,442
+3,825
| +2% | +$14.7K | ﹤0.01% | 3922 |
|
|
2023
Q1 | $667K | Sell |
240,617
-5,659,712
| -96% | -$15.7M | ﹤0.01% | 4037 |
|
|
2022
Q4 | $777K | Buy |
5,900,329
+2,622
| +0% | +$345 | ﹤0.01% | 3988 |
|
|
2022
Q3 | $2.86M | Buy |
5,897,707
+196,599
| +3% | +$95.3K | ﹤0.01% | 3603 |
|
|
2022
Q2 | $3.99M | Buy |
5,701,108
+545,212
| +11% | +$382K | ﹤0.01% | 3496 |
|
|
2022
Q1 | $5.98M | Buy |
5,155,896
+367,477
| +8% | +$426K | ﹤0.01% | 3444 |
|
|
2021
Q4 | $10M | Buy |
4,788,419
+3,862,353
| +417% | +$8.07M | ﹤0.01% | 3204 |
|
|
2021
Q3 | $1.41M | Buy |
926,066
+16,180
| +2% | +$24.6K | ﹤0.01% | 4165 |
|
|
2021
Q2 | $3.25M | Buy |
909,886
+150,223
| +20% | +$536K | ﹤0.01% | 3805 |
|
|
2021
Q1 | $3.62M | Buy |
759,663
+289,557
| +62% | +$1.38M | ﹤0.01% | 3687 |
|
|
2020
Q4 | $2.5M | Buy |
470,106
+393,205
| +511% | +$2.09M | ﹤0.01% | 3608 |
|
|
2020
Q3 | $694K | Buy |
76,901
+6,901
| +10% | +$62.3K | ﹤0.01% | 3747 |
|
|
2020
Q2 | $630K | Buy |
+70,000
| New | +$630K | ﹤0.01% | 3714 |
|